← Eichor
Study identifier: NCT06206369 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

Condition: Aneurysm Abdominal · Peripheral Arterial Disease  ·  Sponsor: Amsterdam UMC, location VUmc

PhaseN/A
Planned participants11000
Who can joinAll sexes, 40 Years to 90 Years
Healthy volunteersNo

About this study

The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).

This description comes directly from the study's public registry record.

Talk to the study team

Kak Khee Yeung, MD, PhD  ·  +31 6 14278725  ·  k.yeung@amsterdamumc.nl

Lotte Rijken, Msc.  ·  l.rijken@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (6)

Hospital District of Helsinki and Uusimaa (HUS)Helsinki, FinlandRecruiting
Asklepios kliniken hamburgHamburg, GermanyRecruiting
Amsterdam UMCAmsterdam, NetherlandsRecruiting
University Hospital Center of São JoãoPorto, PortugalRecruiting
University Clinical Centre of SerbiaBelgrade, SerbiaRecruiting
Oxford University HospitalsOxford, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06206369